Evidence map›Paper›PMID 42793305›Full record

ArticleCurrent issues in molecular biology2026

Candidate Regulatory Relationship and Expression Correlation Between miR-33a-5p and ANK3 in Chronic Myeloid Leukemia.

Nurgul Kar, Sema Misir, Serap Ozer Yaman, Osman Akidan, Ceylan Hepokur, Yuksel Aliyazicioglu

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nurgul KarDepartment of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, 58140 Sivas, Türkiye.
Sema MisirDepartment of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, 58140 Sivas, Türkiye.ORCID 0000-0002-5919-3295
Serap Ozer YamanDepartment of Medical Biochemistry, Trabzon Kanuni Training and Research Hospital, Faculty of Medicine, Trabzon University, 61250 Trabzon, Türkiye.ORCID 0000-0002-5089-0836
Osman AkidanDepartment of Hematology, Mugla Training and Research Hospital, 48000 Mugla, Türkiye.
Ceylan HepokurDepartment of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, 58140 Sivas, Türkiye.ORCID 0000-0001-6397-1291
Yuksel AliyaziciogluDepartment of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Türkiye.ORCID 0000-0001-9474-4307

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic myeloid leukemia (CML) is a type of bone marrow cancer characterized by the uncontrolled proliferation of myeloid cells. MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in the post-transcriptional regulation of gene expression. This study aims to examine the association between miR-33a-5p and Ankyrin 3 (ANK3) in CML and to investigate the regulatory mechanisms of miR-33a-5p in the progression of this disease. mRNA expression profiles were obtained from the GSE100026 dataset within the Gene Expression Omnibus (GEO) repository. Quantitative real-time polymerase chain reaction (RT-qPCR) was conducted to assess the expression levels of miR-33a-5p and ANK3. To investigate the regulatory mechanism of miR-33a-5p/ANK3, various databases such as miRNet, miRDIP, TargetScan, BioGRID, and CancerSEA were utilized. The expression of miR-33a-5p was markedly elevated, while ANK3 expression was significantly reduced. Furthermore, pathway clustering and functional assessments of ANK3 demonstrated its involvement in regulating the cell cycle and apoptosis. The findings identify an inverse expression pattern between miR-33a-5p and ANK3 across the two cell models and support a candidate regulatory relationship that warrants direct functional validation. This relationship may merit further investigation as a potential molecular target in CML.

Indexed as

ankyrin 3chronic myeloid leukemiamicroRNAmiR-33a

Identifiers

PMID42793305
PMCPMC13605770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.